228 related articles for article (PubMed ID: 29527204)
1. Clinical, Immunological, and Molecular Findings in Five Patients with Major Histocompatibility Complex Class II Deficiency from India.
Aluri J; Gupta M; Dalvi A; Mhatre S; Kulkarni M; Hule G; Desai M; Shah N; Taur P; Vedam R; Madkaikar M
Front Immunol; 2018; 9():188. PubMed ID: 29527204
[TBL] [Abstract][Full Text] [Related]
2. MHC-II Deficiency Among Egyptians: Novel Mutations and Unique Phenotypes.
El Hawary RE; Mauracher AA; Meshaal SS; Eldash A; Abd Elaziz DS; Alkady R; Lotfy S; Opitz L; Galal NM; Boutros JA; Pachlopnik Schmid J; Elmarsafy AM
J Allergy Clin Immunol Pract; 2019 Mar; 7(3):856-863. PubMed ID: 30170160
[TBL] [Abstract][Full Text] [Related]
3. MHC class II expression through a hitherto unknown pathway supports T helper cell-dependent immune responses: implications for MHC class II deficiency.
Buch T; Polic B; Clausen BE; Weiss S; Akilli-Ozturk O; Chang CH; Flavell R; Schulz A; Jonjic S; Waisman A; Förster I
Blood; 2006 Feb; 107(4):1434-44. PubMed ID: 16254146
[TBL] [Abstract][Full Text] [Related]
4. Two newly diagnosed HLA class II-deficient patients identified by rapid vector-based complementation analysis reveal discoordinate invariant chain expression levels.
Schmetterer KG; Seidel MG; Körmöczi U; Rottal A; Schwarz K; Matthes-Martin S; Steinberger P; Pickl WF
Int Arch Allergy Immunol; 2010; 152(4):390-400. PubMed ID: 20197681
[TBL] [Abstract][Full Text] [Related]
5. Human leucocyte antigen-identical haematopoietic stem cell transplantation in major histocompatiblity complex class II immunodeficiency: reduced survival correlates with an increased incidence of acute graft-versus-host disease and pre-existing viral infections.
Renella R; Picard C; Neven B; Ouachée-Chardin M; Casanova JL; Le Deist F; Cavazzana-Calvo M; Blanche S; Fischer A
Br J Haematol; 2006 Sep; 134(5):510-6. PubMed ID: 16848795
[TBL] [Abstract][Full Text] [Related]
6. Clinical, Immunological, and Molecular Findings in 57 Patients With Severe Combined Immunodeficiency (SCID) From India.
Aluri J; Desai M; Gupta M; Dalvi A; Terance A; Rosenzweig SD; Stoddard JL; Niemela JE; Tamankar V; Mhatre S; Bargir U; Kulkarni M; Shah N; Aggarwal A; Lashkari HP; Krishna V; Govindaraj G; Kalra M; Madkaikar M
Front Immunol; 2019; 10():23. PubMed ID: 30778343
[TBL] [Abstract][Full Text] [Related]
7. Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients.
Ouederni M; Vincent QB; Frange P; Touzot F; Scerra S; Bejaoui M; Bousfiha A; Levy Y; Lisowska-Grospierre B; Canioni D; Bruneau J; Debré M; Blanche S; Abel L; Casanova JL; Fischer A; Picard C
Blood; 2011 Nov; 118(19):5108-18. PubMed ID: 21908431
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem cell transplantation and other management strategies for MHC class II deficiency.
Picard C; Fischer A
Immunol Allergy Clin North Am; 2010 May; 30(2):173-8. PubMed ID: 20493394
[TBL] [Abstract][Full Text] [Related]
9. Splicing defect in RFXANK results in a moderate combined immunodeficiency and long-duration clinical course.
Prod'homme T; Dekel B; Barbieri G; Lisowska-Grospierre B; Katz R; Charron D; Alcaide-Loridan C; Pollack S
Immunogenetics; 2003 Nov; 55(8):530-9. PubMed ID: 14574520
[TBL] [Abstract][Full Text] [Related]
10. Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency.
Villard J; Lisowska-Grospierre B; van den Elsen P; Fischer A; Reith W; Mach B
N Engl J Med; 1997 Sep; 337(11):748-53. PubMed ID: 9287230
[TBL] [Abstract][Full Text] [Related]
11. Mutation in the class II trans-activator leading to a mild immunodeficiency.
Wiszniewski W; Fondaneche MC; Le Deist F; Kanariou M; Selz F; Brousse N; Steimle V; Barbieri G; Alcaide-Loridan C; Charron D; Fischer A; Lisowska-Grospierre B
J Immunol; 2001 Aug; 167(3):1787-94. PubMed ID: 11466404
[TBL] [Abstract][Full Text] [Related]
12. MHC class II deficiency: Report of a novel mutation and special review.
Farrokhi S; Shabani M; Aryan Z; Zoghi S; Krolo A; Boztug K; Rezaei N
Allergol Immunopathol (Madr); 2018; 46(3):263-275. PubMed ID: 28676232
[TBL] [Abstract][Full Text] [Related]
13. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome).
Steimle V; Otten LA; Zufferey M; Mach B
Cell; 1993 Oct; 75(1):135-46. PubMed ID: 8402893
[TBL] [Abstract][Full Text] [Related]
14. Direct genetic correction as a new method for diagnosis and molecular characterization of MHC class II deficiency.
Matheux F; Ikinciogullari A; Zapata DA; Barras E; Zufferey M; Dogu F; Regueiro JR; Reith W; Villard J
Mol Ther; 2002 Dec; 6(6):824-9. PubMed ID: 12498778
[TBL] [Abstract][Full Text] [Related]
15. Combined immunodeficiency with defective expression in MHC class II genes.
Griscelli C; Lisowska-Grospierre B; Mach B
Immunodefic Rev; 1989; 1(2):135-53. PubMed ID: 2517209
[TBL] [Abstract][Full Text] [Related]
16. Clinical, Immunological, and Genetic Findings in Iranian Patients with MHC-II Deficiency: Confirmation of c.162delG RFXANK Founder Mutation in the Iranian Population.
Mousavi Khorshidi MS; Seeleuthner Y; Chavoshzadeh Z; Behfar M; Hamidieh AA; Alimadadi H; Sherkat R; Momen T; Behniafard N; Eskandarzadeh S; Mansouri M; Behnam M; Mahdavi M; Heydarazad Zadeh M; Shokri M; Alizadeh F; Movahedi M; Momenilandi M; Keramatipour M; Casanova JL; Cobat A; Abel L; Shahrooei M; Parvaneh N
J Clin Immunol; 2023 Nov; 43(8):1941-1952. PubMed ID: 37584719
[TBL] [Abstract][Full Text] [Related]
17. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
[TBL] [Abstract][Full Text] [Related]
18. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
[TBL] [Abstract][Full Text] [Related]
19. Major histocompatibility complex class II deficiency: a clinical review.
Elhasid R; Etzioni A
Blood Rev; 1996 Dec; 10(4):242-8. PubMed ID: 9012922
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
Al-Mousa H; Al-Shammari Z; Al-Ghonaium A; Al-Dhekri H; Al-Muhsen S; Al-Saud B; Arnaout R; Al-Seraihy A; Al-Jefri A; Al-Ahmari A; Ayas M; El-Solh H
Biol Blood Marrow Transplant; 2010 Jun; 16(6):818-23. PubMed ID: 20079864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
